• 19 Jul 2019

SP Angel Healthcare - Morning Comment

Beximco Pharmaceuticals, 34.5 | Novacyt, 258 | Motif Bio, 0.1

    • Vadim Alexandre

    • 4 pages

Stock Image


 
Stock Image


Beximco Pharma (BXP.L): Dividend and tax legislation changes affecting Bangladesh companies | Novacyt (NCYT.L): Completion of sale of Clinical Lab for £400k | Motif Bio (MTFB.L): Receipt of Deficiency Notice from Nasdaq


Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

SP Angel Healthcare Conditions

Companies: Novacyt Avacta Group

Morning Report: Novacyt reports 'unprecedented interest' in its coronavirus diagnostic

Companies: Novacyt

SP Angel Healthcare Conditions

Companies: Novacyt Futura Medical

SP Angel Healthcare Conditions

Companies: Novacyt Creo Medical Group

SP Angel Healthcare Conditions

Companies: Novacyt Redx Pharma

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top